SCHEMBL4446133

SCHEMBL4446133

Cn1nc(C(F)(F)F)c(C(=O)Nc2ccccc2-c2ccc(F)cc2Cl)c1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 7/20 0.50
CYP1A2 P05177 4/20 0.47
CYP3A4 P08684 4/20 0.47
CYP2C19 P33261 4/20 0.47
CYP2C9 P11712 3/20 0.47
GAA P10253 3/20 0.47
CYP2D6 P10635 2/20 0.47
HPGD P15428 1/20 0.46
ALDH1A1 P00352 2/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD11B1 P28845 2/20 0.42
SCN10A Q9Y5Y9 1/20 0.40
ALOX15 P16050 1/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4453760 0.92 CYP1A2 (0.51) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL4916941 0.84 LMNA (0.50) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL4918707 0.84 LMNA (0.52) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL29445414 0.83 LMNA (0.51) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL2997208 0.83 LMNA (0.51) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL4920399 0.83 LMNA (0.52) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL27707930 0.83 LMNA (0.47) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL1085473 0.82 LMNA (0.48) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL27737634 0.81 LMNA (0.46) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4
SCHEMBL22529502 0.81 LMNA (0.65) LMNASMN1; SMN2NPSR1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042724-A1 Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides BASF AKTIENGESELLSCHAFT (DE) 2009-02-12 US claimed
US-20090042724-A1 Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides BASF AKTIENGESELLSCHAFT (DE) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042724-A1 Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides CBR3, CBR1, SNU13 LMNA 3266/4885SMN1; SMN2 2440/4885NPSR1 1099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.